SciVision Biotech (Taiwan) Market Value
| 1786 Stock | TWD 92.00 2.90 3.06% |
| Symbol | SciVision |
SciVision Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SciVision Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SciVision Biotech.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in SciVision Biotech on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding SciVision Biotech or generate 0.0% return on investment in SciVision Biotech over 30 days. SciVision Biotech is related to or competes with Maxigen Biotech, Chunghwa Chemical, Sinphar Pharmaceutical, ScinoPharm Taiwan, and Apex Biotechnology. SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan More
SciVision Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SciVision Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SciVision Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.26) | |||
| Maximum Drawdown | 12.88 | |||
| Value At Risk | (4.01) | |||
| Potential Upside | 3.29 |
SciVision Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SciVision Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SciVision Biotech's standard deviation. In reality, there are many statistical measures that can use SciVision Biotech historical prices to predict the future SciVision Biotech's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | (25.84) |
SciVision Biotech Backtested Returns
SciVision Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.24, which indicates the firm had a -0.24% return per unit of risk over the last 3 months. SciVision Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SciVision Biotech's Variance of 6.01, risk adjusted performance of (0.15), and Coefficient Of Variation of (481.20) to confirm the risk estimate we provide. The entity has a beta of 0.0201, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SciVision Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding SciVision Biotech is expected to be smaller as well. At this point, SciVision Biotech has a negative expected return of -0.6%. Please make sure to validate SciVision Biotech's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if SciVision Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.57 |
Modest predictability
SciVision Biotech has modest predictability. Overlapping area represents the amount of predictability between SciVision Biotech time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SciVision Biotech price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current SciVision Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.57 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 5.18 |
SciVision Biotech lagged returns against current returns
Autocorrelation, which is SciVision Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SciVision Biotech's stock expected returns. We can calculate the autocorrelation of SciVision Biotech returns to help us make a trade decision. For example, suppose you find that SciVision Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
SciVision Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SciVision Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SciVision Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SciVision Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
SciVision Biotech Lagged Returns
When evaluating SciVision Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SciVision Biotech stock have on its future price. SciVision Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SciVision Biotech autocorrelation shows the relationship between SciVision Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in SciVision Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SciVision Stock Analysis
When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.